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Abstract
Background: Peptide identification via tandem mass spectrometry is the basic task of current
proteomics research. Due to the complexity of mass spectra, the majority of mass spectra cannot
be interpreted at present. The existence of unexpected or unknown protein post-translational
modifications is a major reason.
Results:  This paper describes an efficient and sequence database-independent approach to
detecting abundant post-translational modifications in high-accuracy peptide mass spectra. The
approach is based on the observation that the spectra of a modified peptide and its unmodified
counterpart are correlated with each other in their peptide masses and retention time. Frequently
occurring peptide mass differences in a data set imply possible modifications, while small and
consistent retention time differences provide orthogonal supporting evidence. We propose to use
a bivariate Gaussian mixture model to discriminate modification-related spectral pairs from
random ones. Due to the use of two-dimensional information, accurate modification masses and
confident spectral pairs can be determined as well as the quantitative influences of modifications
on peptide retention time.
Conclusion:  Experiments on two glycoprotein data sets demonstrate that our method can
effectively detect abundant modifications and spectral pairs. By including the discovered
modifications into database search or by propagating peptide assignments between paired spectra,
an average of 10% more spectra are interpreted.
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Background
Identification of peptides, especially post-translationally
modified peptides, using liquid chromatography coupled
with tandem mass spectrometry (LC-MS/MS) is the basic
task of current proteomics research [1-3]. Database search
is the most widely used computational approach to pep-
tide identification from mass spectra [4-9]. Other
approaches include de novo sequencing [10-13] and tag-
based approach [14-17]. However, due to the complexity
of mass spectra, the majority (70–90%) of them cannot be
interpreted at present [18]. Among many reasons for the
low interpretation rate of mass spectra, unexpected or
unknown peptide modifications is a major one [19,20].
Identification of modified peptides is usually conducted
in a restrictive manner; that is, a set of variable modifica-
tions are specified before database search. However, there
are hundreds of known natural or artificial modifications
(563 entries in the Unimod [21] database up to July 28,
2008). Most of them have multiple specific sites. There-
fore, it is no practical to select all the modifications for
database search, since this will lead to combinatorial
explosion of search space as well as increased chance of
random matches. In current popular search engines, such
as SEQUEST [4] and Mascot [5], no more than ten varia-
ble modification types are allowed. The problem is that in
most cases we know little about which modifications
occur in the protein sample and exist in the mass spectra
in hand. Most of the time, oxidation on methionine is the
only variable modification specified for database search.
As a result, a large amount of spectra from modified pep-
tides have not been interpreted in the past.
To address the above problem, unrestrictive approaches to
modification identification have been proposed in recent
years [22-25]. MS-Alignment is the first algorithm for
unrestrictive identification of modifications [22,26],
which aligns the experimental spectrum against the theo-
retical spectrum predicted from a peptide in the database
in a modification-tolerant manner, just like the sequence
alignment in genomics. In this way, any modifications
can be identified as long as the two spectra compared
present enough similarities. SPIDER formulates modifica-
tion identification as a dynamic programming problem,
searching for a modified peptide that minimizes the dif-
ference between the de novo sequenced and the database
peptides [25].
Although the above approaches to unrestrictive identifica-
tion of modifications are useful and attractive, they
involve time-consuming database search processes or rely
on good spectrum quality. If we can know the real types
of modifications presented in the spectra prior to database
search, the time spent will be reduced significantly. In fact,
several methods have been proposed to detect modifica-
tions independently of sequence databases [19,27,28].
Due to the dynamic nature of modifications, the modified
and unmodified forms of the same peptide often exist
simultaneously in a protein sample. Mass spectra of mod-
ified and unmodified peptides are correlated with each
other in their peptide masses, LC retention time and frag-
ment peaks. Savitski et al. [19] proposed to use the pep-
tide mass difference histogram constructed from paired
spectra to detect modifications. However, their method
builds on the complementary use of CAD and ECD frag-
mentation modes in the mass spectrometer, and thus is
not applicable to current common proteomic experiments
where only CAD or ECD is used. Potthast et al. [27]
described a method called mass distance fingerprint to
detect modification types from common proteomic mass
spectra. In contrast to their rather complicated statistical
model of mass distribution, they used the peptide mass
information only, limiting the confidence of discoveries.
Bandeira et al. [28] proposed to detect modification-
related spectral pairs by comparing the peptide fragmen-
tation data. Their method is applicable to both abundant
and low-concentration modifications, but at the cost of
computational efficiency.
This paper describes a simple yet efficient approach to
detecting abundant modifications in high-accuracy pep-
tide mass spectra using both peptide mass and retention
time information. Each pair of spectra is represented by a
two-dimensional (2-D) vector composed of the mass dif-
ference and the retention time difference between their
precursor ions. A bivariate Gaussian mixture model is
used to discriminate modification-related spectral pairs
from random ones. In this way, accurate modification
masses and confident spectral pairs can be obtained. We
also use a peptide propagation method to assign peptides
to modification spectra at given false discovery rate (FDR)
without searching a database. Experiments on two glyco-
protein data sets demonstrate the effectiveness of our
method.
Although our method is at present unable (not designed)
to find low-concentration modifications, it possesses sev-
eral advantages compared to previous methods to detect
modifications and spectral pairs:
Fast
Only the peptide mass and retention time information is
used. Computing the spectra similarity based on peptide
fragmentation data enables detection of low-concentra-
tion modifications but is very time-consuming. Clustering
spectra according to the 2-D peptide mass and retention
time data is demonstrated to be very fast. Abundant mod-
ifications and corresponding spectral pairs can be effi-BMC Bioinformatics 2009, 10(Suppl 1):S50 http://www.biomedcentral.com/1471-2105/10/S1/S50
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ciently detected in this way as shown in Results section of
the paper.
Accurate
Peptide retention time is used in addition to peptide
mass. Although using peptide masses alone can also
reveal modifications, retention time provides an inde-
pendent source of supporting evidence. Two features are
far more discriminative in detecting modification-related
spectral pairs than only one feature. Therefore, modifica-
tion masses and identities can be more accurately deter-
mined.
Robust
Our approach to modification and spectral pair discovery
is independent of peptide fragmentation data. It is known
that modified peptides often have complex fragmentation
patterns. For example, phosphorylated peptides often
undergo insufficient fragmentation, resulting in domi-
nant neutral-loss precursor peaks. Peptides of cation mod-
ifications have even poorer fragmentation spectra with
reduced fragment signals according to our observation.
Therefore, those methods using peptide fragmentation
data to measure the spectra similarity are unreliable to
detect pairs of poorly fragmented spectra. The method
proposed in this paper is naturally immune to this prob-
lem.
Methods
Roughly speaking, we use two steps to look for modifica-
tions. In the first step, the peptide masses are used alone
to obtain a list of candidate modification masses. In the
second step, for each candidate modification mass, the
retention time is added to validate the modification. Each
possible pair of spectra is represented by a 2-D vector of
peptide mass difference and retention time difference.
Then, a bivariate Gaussian mixture model is used to differ-
entiate modification-related spectral pairs from random
ones. By doing this, the accurate modification mass values
can be estimated and the influence of the modifications
on retention time can be characterized. Before all of these
analyses, the spectra data set is first reduced to remove
redundancy, as described below.
Removal of spectra redundancy
In tandem mass spectrometry, abundant peptides will
produce many duplicate spectra, leading to data redun-
dancy. The disadvantages of spectra redundancy in our
problem lie in two folds. First, redundancy brings high
computational burden. Since we are dealing with the pep-
tide mass and retention time differences between all pairs
of spectra, the size of the problem increases quadratically
with the number of spectra. Second and no less impor-
tant, the spectra redundancy may cause unexpected effect
on the distributions of peptide mass and retention time
differences. The retention time of abundant peptides may
possibly distribute across a large range. This is obviously
undesirable for our analysis. To remove the spectra redun-
dancy, among all the spectra whose peptide mass values
are within a small window (e.g. 5 ppm for FT instru-
ments), only one of them is reserved as the representative
spectrum and all other spectra are removed. Of course,
spectra of close peptide masses may not be produced by
the same peptide and some spectra may be falsely
removed as redundant spectra. However, this hardly
affects our analysis. We find that a representative subset of
spectra is already enough to reveal the dominant modifi-
cations.
Detection of candidate modification masses
Given a set of peptide mass spectra, the peptide mass dif-
ferences (denoted by m) between all pairs of spectra are
calculated. As an example, Figure 1 illustrates the m his-
togram for data set 1 (described in the Results section).
Only those m of relatively small values (0–100 Da here)
are considered in this paper, since most modifications are
small molecules. As stated previously, for abundant mod-
ifications, modified and unmodified peptides tend to be
present simultaneously in the sample. Therefore, frequent
m may correspond to possible peptide modifications.
Those m of significantly high frequency are considered as
candidate modification masses, which will be further val-
idated according to their corresponding retention time
shifts.
To detect statistically significant high-frequency m, some
probabilistic approach has to be employed. Since peptide
masses (and consequently their differences) cluster
around unit values, it is inappropriate to assume that all
m are equally probable. One option is to assume that
random m follow a mixture of Gaussian distributions
centred on unit mass values, and use peptides randomly
generated or from some database to generate this mixture
distribution. However, it is unknown to what extent this
assumption holds and the estimated distribution fits the
real spectra data. Instead of using a complicated model, in
this paper we resort to a simple yet practically effective
approach to the problem posed. For each mass window of
one Da around a unit mass value (i), the most frequent
m (denoted by mf) is extracted, that is,
where counts(m) is the number of occurrences of m and
n is the number of mass windows. While most   are
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random events, some may result from peptide modifica-
tions. We observe that the frequency, i.e. counts(mf), of
random mf approximately follows a Gaussian distribu-
tion, as shown in Figure 2. Since it is unknown what type
of distribution the frequency of modification-induced mf
comes from, we use a heuristic way to estimate the ran-
dom part of counts(mf). Let cmin and cmed denote the min-
imum and the median of counts , respectively.
Then, those counts( ) smaller than 2cmed - cmin are used
to estimate the parameters, i.e., mean and variance, of the
random Gaussian distribution of counts(mf). Then, for
each ,  a  p-value is calculated based on this Gaussian
distribution. Those   with p-values less than a given
threshold are considered as candidate modification
masses.
Validation of candidate modification masses
After a list of candidate modification masses are found
through the above steps, the next task is to filter out false
positives and select a high-confidence subset, since it is
possible that the high frequencies of some m found in
step 1 may be just due to chance rather than real modifi-
cations. Given that we do not want to use the fragment
peak information (for simplicity and efficiency), it is nec-
essary to look for other type of evidence to verify the can-
didate modification masses.
In LC-MS/MS experiments, in addition to the peptide
masses, the retention time of peptides is another type of
m histogram for data set 1 Figure 1
m histogram for data set 1. Frequent m are possibly derived from abundant modifications, because modified and 
unmodified peptides usually occur simultaneously in the sample.
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information readily available. Since the peptide retention
time is orthogonal to the peptide mass, it is an important
source of evidence to validate the modifications. The
modified and the unmodified forms of a peptide share the
same amino acid sequence and differ by a modification
group only. As a result, they are similar in physical and
chemical properties and thus LC behaviour, i.e. retention
time. A modification usually has a relatively small and
consistent effect on the retention time of peptides. There-
fore, we can expect that if a high-frequency m is truly due
to a modification, spectral pairs of this m will show con-
sistent differences in peptide retention time. For example,
a modification may tend to increase or decrease the reten-
tion time of peptides to some extent, or simply have no
significant influence at all. If a candidate modification
mass is accompanied with a wild distribution of retention
time differences, this candidate is very likely to be a false
alarm.
An intuitive way to implement the above analyses is to
show the mass differences and the retention time differ-
ences (denoted by Rt) together in a 2-D histogram. As an
example, Figure 3 illustrates a m and Rt histogram for
the carbamidomethylation modification found in data set
1 (see Results section for details). For simplicity, the scan
number is used as a substitute for the retention time in
this paper. We can see that there is a sharp peak in the his-
togram, which is produced by the spectral pairs of this
modification. As shown, the modification mass is about
57 Da and the modification does not lead to a significant
increase or decrease in the peptide retention time. The
accurate modification mass and retention time shift can
be automatically determined in a statistical framework
described below.
Estimation of mixture distribution
Each pair of spectra is represented by a 2-D vector
(denoted by ) composed of peptide mass difference m
and retention time difference Rt between the two spec-
tra, i.e.,
 = m, Rt.
Frequency Distribution of high-frequency m (mf) for data set 1 Figure 2
Frequency Distribution of high-frequency m (mf) for data set 1. The random part of the distribution is very close to 
a Gaussian distribution, based on which the p-value of a   being random can be computed. Δmi
fBMC Bioinformatics 2009, 10(Suppl 1):S50 http://www.biomedcentral.com/1471-2105/10/S1/S50
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We assume that in the vicinity (e.g. ± 0.5 Da) of each mod-
ification mass,  follows a bivariate Gaussian mixture dis-
tribution with two components, one of which is produced
by random spectral pairs and the other by modification-
related spectral pairs, or formally,
where G(, ) is the Gaussian distribution with mean 
and covariance matrix , subscripts Rand and Mod denote
random and modification-related spectral pairs, respec-
tively, and Rand and  Mod are mixing coefficients. The
parameters of the mixture distribution can be estimated
using the Expectation-Maximization (EM) algorithm.
Figure 4 shows the  distribution around the unit mass
value 22 for data set 1. We can see that the majority of the
data follow Gaussian-alike distributions along both
dimensions, with a sharp peak in each distribution center.
The sharp peaks, which are in fact produced by the cat-
ion:Na modification, can also be fitted by Gaussian distri-
butions.
Detection of spectral pairs
After the modification-related and the random distribu-
tions of  are estimated in the above step, modification-
related spectral pairs can be identified at given posterior
error rate. Given an observation of , the posterior proba-
bility of the corresponding spectral pair being modifica-
tion-related is
where f is the Gaussian probability density function:
2-D histogram of m and Rt for the carbamidomethylation modification found in data set 1 Figure 3
2-D histogram of m and Rt for the carbamidomethylation modification found in data set 1. The sharp peak in 
both dimensions indicates the actual presence of this modification in the sample, since a modification must cause a fixed change 
in peptide mass and a slight shift in retention time.
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Scatter-histogram of  around the unit mass value 22 for data set 1 Figure 4
Scatter-histogram of  around the unit mass value 22 for data set 1. The  in the vicinity of each modification mass 
are assumed to come from a mixture of two Gaussian distributions produced by the random and the modification-related 
spectral pairs, respectively. The dense data points in the red square, which are automatically localized using the EM algorithm, 
are mostly derived from modification-related (cation:Na) spectral pairs.BMC Bioinformatics 2009, 10(Suppl 1):S50 http://www.biomedcentral.com/1471-2105/10/S1/S50
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Spectral pairs with posterior probability larger than the
given threshold are accepted as true modification-related
spectral pairs.
Propagation of peptide assignments
After high-confidence modification-related spectral pairs
are found out, the peptide assigned to one spectrum can
be propagated to its paired spectrum. It is expected that
many spectra that cannot be assigned peptides to via
standard database search can be identified in this way.
This is especially useful for modification spectra of low
signal/noise ratios. For example, according to our obser-
vation, cations usually prevent peptides from sufficient
fragmentation, resulting in few signal fragment peaks. In
addition, some modifications can occur at many sites. For
example, according to the annotations in the Unimod
database, the carbamidomethylation can possibly occur at
the N-term of any peptides and five amino acids any-
where. It is not practical to specify too many variable
modifications in current database search engines, which
will greatly increase the time of database search and the
chance of false positive identifications. Therefore, direct
propagation of peptide assignments among paired spectra
will be a promising and efficient approach to identifying
modified peptides and increasing the interpretation rate
of spectra, a major expectation in the proteomics commu-
nity.
Inference of modification types
For spectra of high mass accuracy, e.g. spectra produced
from FT spectrometers, the m values can be resolved in
ppm level. Although we used 0.01 Da as the bin width in
the m histogram, more accurate values of modification
masses can be obtained by fitting the 2-D distribution of
. Retention time difference Rt, as an additional source
of information can exclude many random spectral pairs.
With accurate modification masses, the types of common
modifications can be easily determined by searching
modification databases, e.g., Unimod. Retention time
shift is another type of evidence to infer modification
types. Different modifications have different influences
on the retention time of peptides. For example, we
observe that oxidation tends to decrease the retention
time (by about 700 scans as shown in Table 2). Some rare
or unknown modifications may not be registered in data-
bases. In this case, the molecular formula of a modifica-
tion has to be manually inferred. Special attention should
be paid to cation modifications. For an n+ cation, the
resulting m is the atomic mass of this cation minus n
proton masses. See data sets 1 and 2 in this paper for
examples of cation modifications.
Results and discussion
We used two data sets of mass spectra to test our algo-
rithm. Both data sets were produced from glycoprotein
samples. The reason lies in that in order to identify glyco-
sylated peptides, protein samples have to undergo com-
plex treatments, which can possibly introduce chemical
modifications. We show that modifications can be effi-
ciently discovered using our algorithm and either includ-
ing the modifications into the database search process or
directly propagating peptides between paired spectra can
significantly increase the number of spectra interpreted.
Data
Data set 1
Ig G depleted human plasma from a healthy donor was
mixed with WGA, Con A and JAC lectins to enrich most
glycoproteins. Then the glycoproteins were reduced,
alkylated and digested by trypsin and PNGase F, followed
by LC-MS2 analysis. After treating the glycopeptides with
PNGase F, the deglycosylated peptides had a +0.984 Da
mass drift on asparagine to aspartate. LC-MS2 experiments
were performed on an LTQ-FT mass spectrometer. The
LTQ-FT mass spectrometer was operated in the data-
dependent mode. A full scan survey MS experiment was
acquired in the FT-ICR mass spectrometer, and the five
most abundant ions detected in the full scan were ana-
lyzed by MS2 scan events. This resulted in a total of 8,654
MS2 mass spectra.
Data set 2
Ig G depleted human plasma from a healthy donor was
mixed with LCH lectins to enrich core fucosylated glyco-
proteins; then the glycoproteins were reduced, alkylated
and digested by trypsin and Endo F3 (treatment with
Endo F3 released partial oligosaccharide chain, and leaved
the fucosyl GlcNAc reside on the peptides). Samples were
separated by SCX and RP HPLC, and then sent to an LTQ-
FT mass spectrometer. A full scan survey MS experiment
was acquired in the FT-ICR mass spectrometer, and the
five most abundant ions detected in the full scan were
analyzed by MS2 scan events. An MS3 spectrum was auto-
matically collected when one of the top three intense
peaks from the MS2 spectrum corresponded to a neutral
loss event of 73.0290 m/z, 48.6860 m/z and 36.5145 m/
z. Among the resulted MS3 mass spectra, those that were
sure to be from core fucosylated glycopeptides were
selected out intelligently in a post-processing step [29].
The final data set consists of a total of 1,528 MS3 mass
spectra considered to have been generated from core fuc-
osylated glycopeptides.
Discovered modifications and spectral pairs
Tables 1 and 2 list the modifications and the number of
related spectral pairs discovered in data sets 1 and 2,
respectively. The modification masses and the retention
time (scan number) shift caused by modifications are
automatically learned using the algorithm presented
above. The number of spectral pairs related by each mod-BMC Bioinformatics 2009, 10(Suppl 1):S50 http://www.biomedcentral.com/1471-2105/10/S1/S50
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ification with posterior probabilities above 0.98 is also
given. It is shown that the modification mass values deter-
mined from data are very accurate, up to the level of 0.001
Da or even 0.0001 Da. This high mass accuracy is largely
due to the use of retention time as a second dimension for
detecting spectra pairs. Using peptide masses alone would
result in a much lower mass accuracy, e.g. 0.01 Da or so.
With a high mass accuracy, the modification types can be
easily identified by searching the Unimod modification
database. In addition, since the peptide fragmentation
data is not used in our algorithm, the computational proc-
ess is very fast. Except the time for loading mass spectra
data from disk, only a couple of minutes are needed.
Among the discovered modifications, some are common
in LC-MS/MS experiments, e.g., oxidation, carbamid-
omethylation and water-/ammonia-loss. Carbamid-
omethylation is usually specified as a fixed modification
on cysteine as an artifact for database search. However, we
show here that carbamidomethylation may occur on
more specific sites abundantly in a variable manner. Mod-
ifications of important biological functions are also
found. Methylation is an in vivo post-translational modi-
fication, while deamidation can occur both in vivo and in
vitro. Other modifications may have been introduced by
special sample treatments or from samples themselves,
e.g., the sodium cation coming from digestion buffer of
glycosidase or lectin binding buffer commonly used in the
glycoproteomics research and the iron cation coming
from hematoglobins in plasma.
Two types of cation modifications are found. They are the
sodium cation (cation:Na) in data set 1 and the very abun-
dant 2+ iron cation (cation:Fe(II)) in data set 2. The Fe(II)
modification (about 54 Da) is not registered in the Uni-
mod database and has not been reported before. Note that
the Fe(III) modification (about 53 Da) has been found
and reported [22,30]. Three evidences make us very confi-
Table 1: Modifications and spectral pairs found in data set 1
m (Da) Rt (Scans) # of spectral pairs (pp 
> 0.98)*
Modification type Theoretical mass (Da) Unimod AC #
Mean ± 3Sigma Mean ± 3Sigma
57.0221 ± 0.0186 -31.4 ± 387.1 2303 Carbamidomethylation 57.0215 4
21.9839 ± 0.0108 -10.5 ± 276.2 319 Cation:Na 21.9819 30
17.0254 ± 0.0201 -353. 2 ± 1360.0 0 Ammonia-loss/Gln  
pyro-Glu
17.0265 385/28
14.0157 ± 0.0178 -677.6 ± 1012.6 0 Methylation/Asp  
Glu
14.0157 34/558
0.98943 ± 0.0603 176.6 ± 1152.6 0 Amidation/
Deamidation
0.98402 2/7
*pp stands for the posterior probability of being modification-related. 3Sigma stands for three times of standard deviation. For the last three 
modifications, spectral pairs of pp > 0.98 are not detected out. This is due to the less abundance of these modifications. However, this does not 
prevent the algorithm from accurately estimating their masses.
Table 2: Modifications and spectral pairs found in data set 2.
m Rt # of spectral pairs (pp > 
0.98)
Modification type Theoretical mass Unimod AC #
Mean ± 3Sigma Mean ± 3Sigma
53.9177 ± 0.0180 -15.3 ± 222.3 5236 Cation:Fe(II) 53.9193 None
15.9942 ± 0.0090 -685.3 ± 762.3 4613 Oxidation 15.9949 35
0.9959 ± 0.0395 47.4 ± 254.9 305 Amidation/Deamidation 0.9840 2/7
18.01 N/A N/A N/A N/A Water-loss/Glu  pyro-
Glu*
18.0106 23/27
57.02 N/A N/A N/A N/A Carbamidomethylation* 57.0215 4
*Those modifications are found from the 1-D m histogram and manually validated by 2-D <m, Rt> histogram, but the data points for them are 
too few to effectively estimate their m and Rt distributions.BMC Bioinformatics 2009, 10(Suppl 1):S50 http://www.biomedcentral.com/1471-2105/10/S1/S50
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dent of the identity of the Fe(II) modification. First, the
empirical mass is very close to the theoretical one – a dif-
ference of only 0.0016 Da. Second, the retention time
shift (Rt) caused by this modification is very small, just
like other cations, e.g. sodium. Third, we observe that a
large proportion of spectra with this modification have
higher charge states than their paired spectra without this
modification. This can be explained by a polyvalent-cat-
ion modification.
Improvements on peptide identification
There are two ways to make use of the found modification
types to improve peptide identification. The most com-
mon way is to include them as variable modifications into
the database search process. The other is to directly prop-
agate peptide between paired spectra without re-searching
the database. Both experiments are conducted. Tables 3
and 4 give the peptide identification results on data sets 1
and 2, respectively. Database search is performed using
the pFind search engine [7,31] and the target-decoy data-
base method [32] is used to estimate the FDR of search
results. For data set 1, we include the deamidation (at N)
introduced by sample preparation and the common oxi-
dation (at M) as variable modifications in the first round
of database search. Then, the most abundant carbamid-
omethylation (at N-term and K) is added in the second
round of database search. As a result, 301 more spectra are
interpreted, although the increase in the number of pep-
tide identifications is trivial. Based on the first-round data-
base search results, peptide propagation is carried out. It
turns out that 537 spectra with the carbamidomethylation
modification are assigned with peptides at the same FDR
(2%) as database search (we use the maximum posterior
error probability as a conservative estimate of FDR, which
in theory is larger than actual FDR). Moreover, after pep-
tide propagation between spectra paired by the cation:Na
modification, 134 more spectra are assigned with pep-
tides. On data set 2, inclusion of oxidation into the data-
base search increases the number of interpreted spectra by
22, while peptide propagation between spectral pairs
related by the cation:Fe(II), oxidation and deamidation
increases the number of interpreted spectra by 143, 33
and 19, respectively. Note that cation modifications, e.g.
Na and Fe adduct cannot be added into database search as
variable modifications. This is because it is not clearly
known which amino acids the cations are attached to and
the spectra with cation modifications usually have very
low signal/noise ratio according to our observation. On
average, an increase of 10% in spectra interpretation rate
is obtained on these two data sets after considering the
discovered modifications.
To sum up, experimental results demonstrate that includ-
ing the detected modification types into database search
can increase the number of interpreted spectra to some
extent, while direct peptide propagation between spectral
pairs related by modifications can interpret even more
spectra. Moreover, it seems that spectra with cation mod-
ifications can only be effectively assigned with peptides by
peptide propagation.
Conclusion
In this paper, we have presented a method for detecting
abundant modifications in peptide mass spectra using the
peptide mass and retention time differences. The method
is more accurate than those using peptide masses only and
is more efficient than those using peptide fragmentation
data. One disadvantage of our method is that it cannot
Table 3: Peptide identification and propagation results on data set 1 (FDR < 2%)
Variable modifications # of peptides identified # of spectra interpreted
All Glycosylated
DB search Deamidation (N) 479 79 3514
Oxidation (M)
Deamidation (N) 484 82 3815
Oxidation (M)
Carbamidomethylation (N-term)
Carbamidomethylation (K)
Peptide propagation* Carbamidomethylation - - +537
Cation:Na - - +134
*Peptide propagation is conducted based on the peptide identification results of the first-round database search (first row in the table body). 
Peptide propagation cannot identify more peptides, but significantly increases the number of interpreted spectra.BMC Bioinformatics 2009, 10(Suppl 1):S50 http://www.biomedcentral.com/1471-2105/10/S1/S50
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detect low-concentration modifications. But we argue that
this method is not designed for this purpose. By using a
statistical framework, very accurate modification masses
can be obtained and the influence of modifications on the
peptide retention time can be quantified. Moreover, mod-
ification-related spectral pairs can be detected at a given
posterior error rate. An interesting phenomenon observed
in this paper is that propagating peptides between paired
spectra can interpret even more spectra of modified pep-
tides than including the discovered modifications into
database search. Peptide propagation is particularly useful
for identifying peptides of cation modifications. In the
future, we wish to test the method on more proteomic
data sets and incorporate more information to cluster
spectra.
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